Join ReciBioPharm at the mRNA Design and Delivery Congress from March 13-14, 2024, Boston, USA
ReciBioPharm combines the capabilities of CDMOs Arranta Bio, GenIbet, and Vibalogics as a trusted partner for biologics drug development and manufacturing services.
With our expanded portfolio of cutting-edge technologies and expertise, we offer a comprehensive suite of solutions to accelerate the production of complex therapeutics such as plasmid DNA, RNA-based therapies, viral-based vaccines.
Innovation is at the heart of ReciBioPharm, exploring uncharted territories in drug development. By forging strategic partnerships with leading biotech companies, we accelerate the translation of scientific discoveries into tangible clinical solutions.
Every breakthrough, drug candidate, and therapeutic innovation we help develop is driven by a commitment to improving human health. We aim to transform the lives of patients worldwide and drive meaningful impact across the healthcare landscape.
Meet us at the mRNA Design & Delivery Congress to discover first-hand how we are shaping the future of medicine and empowering healthcare providers with ground-breaking therapies that revolutionize the way we approach drug development.